Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis

23 Sept 2023

Abstract excerpt

BACKGROUND: In juvenile idiopathic arthritis (JIA) clinical remission is unattainable in some patients despite modern biologic disease-modifying antirheumatic drugs (bDMARD) therapy and switching bDMARD is required. The best choice of second-line bDMARD remains unclear. This retrospective observational study aims to describe the pattern, timing, frequency, and reasons for bDMARD switching among children diagnosed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Ocular Diseases and Behçet’s Syndrome
Share to Rheumatoid Arthritis Research and Therapies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37742033
DOI: 10.1186/s12969-023-00897-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritisPMID 37742033Read ↗

Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort studySemantic proximity Read ↗

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Semantic proximity Read ↗

The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.Semantic proximity Read ↗

HLA-DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis.Semantic proximity Read ↗

Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?Semantic proximity Read ↗

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugsSemantic proximity Read ↗

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomySemantic proximity Read ↗

Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis.Semantic proximity Read ↗

Continuous effectiveness and safety after a hospital-wide switch to adalimumab biosimilar: an observational study in rheumatoid arthritis patientsSemantic proximity Read ↗

Antibiotic Exposures and the Likelihood of Developing Pediatric Autoimmune Diseases: a Register-based Matched Case-control StudySemantic proximity Read ↗

An immunome perturbation is present in juvenile idiopathic arthritis patients who are in remission and will relapse upon anti-TNFα withdrawalSemantic proximity Read ↗

What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.